Your healthcare provider can assess whether continuing semaglutide with enhanced reflux control, switching to a different GLP-1 medication, or exploring oral formulations might better suit your needs
The peptide safety and risks guide covers contamination prevention in comprehensive detail
This dual action helps in effective weight management, particularly when combined with diet and exercise
What should you know before using KLOW
Dahl D, Onishi Y, Norwood P et al (2022) Effect of subcutaneous tirzepatide vs placebo added to titrated insulin glargine on glycemic control in patients with type 2 diabetes: the SURPASS-5 randomized clinical trial
Pure GIP agonists, when tested without GLP-1 agonism, havent shown impressive weight loss results in early studies